source
- ARPA-H launches ADVOCATE program to fund AI agents for health tech companiesARPA-H, the federal agency that funds breakthrough health technologies, announced the start of a new initiative called ADVOCATE. The program will award millions of dollars in grants to health-tech…
- FDA imposes partial clinical hold on Biohaven's experimental epilepsy drug BHV-7000FDA announced a partial clinical hold on Biohaven's ion channel program, affecting the epilepsy trial of the experimental drug BHV-7000. The hold was issued after the agency requested additional p…